Head-to-head dispatch
FuturHealth vs Rebody Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added
$199/mo (compounded) sema · Verified July 20, 2026
Marked down on: Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
Desk Score
Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front.
$200/mo (starting dose, compounded) sema · $250/mo (starting dose, compounded) tirz · Verified July 21, 2026
Marked down on: Individual compounding pharmacies are not named on the marketing site
Rebody Health takes this head-to-head with the higher Desk Score, 79/100 (C+) against 56/100 (C) for FuturHealth. FuturHealth still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
FuturHealth
56/100
C
Rebody Health
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | FuturHealth | Rebody Health |
|---|---|---|
| Semaglutide | $199/mo (compounded) | $200/mo (starting dose, compounded) |
| Tirzepatide | Not listed on FuturHealth's site (checked July 20, 2026) | $250/mo (starting dose, compounded) |
| Coverage | Not listed on FuturHealth's site (checked July 20, 2026) | 47 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Brand-name and compounded GLP-1s with registered-dietitian coaching. | Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options. |
| Desk Score | 56/100C | 79/100C+ |
The verdict
Desk pick — Rebody HealthRebody Health takes this head-to-head with the higher Desk Score, 79/100 (C+) against 56/100 (C) for FuturHealth. FuturHealth still holds its ground where its strengths line up with yours.
Choose FuturHealth if…
Brand-name and compounded GLP-1s with registered-dietitian coaching.
$199/mo (compounded) sema
Choose Rebody Health if…
Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options.
$200/mo (starting dose, compounded) sema · $250/mo (starting dose, compounded) tirz · 47 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: FuturHealth · Rebody Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs FuturHealth
- CoreAge Rx vs Rebody Health
- FuturHealth vs Vaylen
- Rebody Health vs Vaylen
- FuturHealth vs RxSpan MD
- Rebody Health vs RxSpan MD
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.